Cargando…

Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice

Identification of new pharmacological approaches to inhibit the excessive fat intake-induced steatohepatitis and chronic kidney disease (CKD) is important. High-fat diet (HFD)-induced steatohepatitis and CKD share common pathogenesis involving peroxisome proliferator-activated receptor (PPAR)-α and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Hung-Cheng, Chang, Fu-Pang, Li, Tzu-Hao, Liu, Chih-Wei, Huang, Chia-Chang, Huang, Shiang-Fen, Yang, Ying-Ying, Lee, Kuei-Chuan, Hsieh, Yun-Cheng, Wang, Ying-Wen, Lee, Tzung-Yan, Huang, Yi-Hsiang, Hou, Ming-Chih, Lin, Han-Chieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607733/ https://www.ncbi.nlm.nih.gov/pubmed/31321239 http://dx.doi.org/10.1155/2019/6740616

Ejemplares similares

SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH mice
por: Liu, Chih-Wei, et al.
Publicado: (2020)

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice
por: Liu, Szu-Yu, et al.
Publicado: (2022)

Propranolol Suppresses the T-Helper Cell Depletion-Related Immune Dysfunction in Cirrhotic Mice
por: Tsai, Hung-Cheng, et al.
Publicado: (2020)

Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model
por: Su, Yen-Bo, et al.
Publicado: (2018)

Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-Analysis
por: Li, Tzu-Hao, et al.
Publicado: (2020)

Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis
por: Li, Tzu-Hao, et al.
Publicado: (2016)

TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients
por: Fan, Wen-Chien, et al.
Publicado: (2016)

Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study
por: Li, Tzu-Hao, et al.
Publicado: (2021)

Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men
por: van den Hoek, Anita M., et al.
Publicado: (2021)

Urinary fatty acid and retinol binding protein-4 predict CKD progression in severe NAFLD patients with hypertension: 4-year study with clinical and experimental approaches
por: Tsai, Yu-Lien, et al.
Publicado: (2020)

Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

Early echocardiographic signs of diastolic dysfunction predict acute kidney injury in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2020)

Intestinal SIRT1 Deficiency-Related Intestinal Inflammation and Dysbiosis Aggravate TNFα-Mediated Renal Dysfunction in Cirrhotic Ascitic Mice
por: Chou, Yu-Te, et al.
Publicado: (2021)

Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor
por: Kamata, Shotaro, et al.
Publicado: (2023)

Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats
por: Li, Tzu-Hao, et al.
Publicado: (2016)

Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats
por: Liu, Szu-Yu, et al.
Publicado: (2021)

Aliskiren Attenuates Steatohepatitis and Increases Turnover of Hepatic Fat in Mice Fed with a Methionine and Choline Deficient Diet
por: Lee, Kuei-Chuan, et al.
Publicado: (2013)

Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice
por: Lee, Kuei-Chuan, et al.
Publicado: (2016)

Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2021)

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
por: Roth, Jonathan D., et al.
Publicado: (2019)

Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score
por: Hsieh, Yun-Cheng, et al.
Publicado: (2018)

Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury
por: Hsieh, Yun-Cheng, et al.
Publicado: (2021)

Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase
por: Chang, Chih-Chun, et al.
Publicado: (2011)

Transcriptomics data of a human in vitro model of non-alcoholic steatohepatitis exposed to elafibranor
por: Boeckmans, Joost, et al.
Publicado: (2019)

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection
por: Chien, Shih-Chieh, et al.
Publicado: (2022)

Reduced Risk of Sepsis and Related Mortality in Chronic Kidney Disease Patients on Xanthine Oxidase Inhibitors: A National Cohort Study
por: Yang, Huang-Yu, et al.
Publicado: (2022)

Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis
por: Hsu, Yun‐Shiuan O., et al.
Publicado: (2019)

Endoscopic management versus radical nephroureterectomy for localized upper tract urothelial carcinoma in a high endemic region
por: Chen, Yung-Tai, et al.
Publicado: (2021)

Carotid arterial mechanics as useful biomarker of extracellular matrix turnover and preserved ejection fraction heart failure
por: Zhou, Kevin Ning, et al.
Publicado: (2020)

Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection
por: Lee, Yu-Hsiang, et al.
Publicado: (2017)

Coronary CT angiography-based estimation of myocardial perfusion territories for coronary artery FFR and wall shear stress simulation
por: Hsieh, Yu-Fang, et al.
Publicado: (2021)

Risk Factors for Development of Septic Shock in Patients with Urinary Tract Infection
por: Hsiao, Chih-Yen, et al.
Publicado: (2015)

(Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway
por: Hsieh, Yun-Cheng, et al.
Publicado: (2021)

The AMPK Agonist AICAR Inhibits TGF-β1 Induced Activation of Kidney Myofibroblasts
por: Chen, Kuan-Hsing, et al.
Publicado: (2014)

Development of a Novel Hanging Drop Platform for Engineering Controllable 3D Microenvironments
por: Cho, Chin-Yi, et al.
Publicado: (2020)

Null effect of ginsenoside Rb1 on improving glycemic status in men during a resistance training recovery
por: Chang, Wei-Hsiang, et al.
Publicado: (2015)

Revision Total Hip Arthroplasty with Primary Stem or Full-Porous-Coated Long Stem for Aseptic Femoral Component Loosening: A Matched-Pair Study
por: Tsai, Meng-Huan, et al.
Publicado: (2022)

Long-Term Outcome of Leptospirosis Infection with Acute Kidney Injury
por: Chang, Chih-Hsiang, et al.
Publicado: (2022)

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
por: Chou, Cheng-Wei, et al.
Publicado: (2019)

In-Situ observation of local atomic structure of Al-Cu-Fe quasicrystal formation
por: Parsamehr, Hadi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ame2od8skkp9ejl9rb2taa2kvi